| Literature DB >> 32095227 |
Ichiro Okano1, Stephan N Salzmann1, Courtney Ortiz Miller1, Colleen Rentenberger1, Paul Schadler1, Oliver C Sax1, Jennifer Shue1, Andrew A Sama1, Frank P Cammisa1, Federico P Girardi1, Alexander P Hughes1.
Abstract
N-terminal telopeptide (NTX) is a bone resorption marker that is commonly referenced in clinical practice. Bone remodeling is also associated with changes in mineral components. Fourier transform infrared spectroscopy (FTIR) is utilized in the assessment of bone material properties and some parameters are reported to have associations with bone remodeling. The aim of this cross-sectional study is to investigate the relationship between uNTX levels and FTIR parameters, utilizing prospectively collected study data for patients who underwent lumbar fusion surgery. Bone specimens were taken from iliac crest (IC) and vertebrae (V). Cortical (C) and trabecular (T) bones were separately analyzed. 22 patients (mean age 60.0 years (35.9-73.3), male : female 9 : 13) were included in the final analysis. Women showed significantly higher uNTX levels (male : female, median [range] 21.0 [11.0-39.0] : 36.0 [15.0-74.0] nM·BCE/mM, p=0.033). Among women, a significant positive correlation was observed between uNTX and mineral-to-matrix ratio in IC-C. Among men, uNTX demonstrated significant negative correlation with collagen crosslinks (XLR: ratio of mature to immature collagen crosslinks) in IC-C, V-T, and V-C. In addition, uNTX was positively correlated with acid phosphate substitution (HPO4, a parameter of new bone formation) in IC-C, IC-T, and V-C. After age adjustment, HPO4 in IC-T and V-C among men showed significant positive associations with uNTX (IC-T: p=0.018, R 2 = 0.544; V-C: p=0.007, R 2 = 0.672). We found associations between FTIR parameters and uNTX in men, but not in women. The correlations between uNTX and FTIR parameters in men might suggest a better balance of bone breakdown (uNTX) and new bone formation (FTIR parameters: XLR, HPO4) than in women.Entities:
Year: 2020 PMID: 32095227 PMCID: PMC7036120 DOI: 10.1155/2020/5725086
Source DB: PubMed Journal: J Osteoporos ISSN: 2042-0064
Summary of FTIR parameters.
| Parameter | Abbreviation | Definition | Validation |
|---|---|---|---|
| Mineral-to-matrix ratio | Min/Mat | Area of phosphate (916 to 1180 cm−1) band/area of amide I (1596 to 1712 cm−1) band | Bone mineral content, correlated to ash weight |
|
| |||
| Carbonate-to-phosphate ratio | C/P | Area of the carbonate (852 to 890 cm−1) band/area of the phosphate (916 to 1180 cm−1) band | The level of carbonate substitution in the hydroxyapatite (HA) crystal |
|
| |||
| Crystallinity | XST | Intensity ratio of subbands at 1030/1020 cm−1 | Mineral crystal size and perfection as determined by X-ray diffraction |
|
| |||
| Collagen cross link | XLR | Intensity ratio of amide I subbands at 1660/1690 cm−1 | Collagen cross-link network maturity, ratio of mature and immature collagen crosslinks |
|
| |||
| Acid phosphate substitution | HPO4 | Intensity ratio of subband at 1128/1096 cm−1 | The substitution of HPO4− ions into hydroxyapatite lattice, characteristics of younger mineral |
Patient demographics.
| Factor | Overall | Male | Female |
| |
|---|---|---|---|---|---|
|
| 22 | 9 | 13 | ||
| Age | Median (range) | 60.02 [35.96, 73.25] | 60.20 [35.96, 71.00] | 59.85 [42.13, 73.25] | 0.556 |
| BMI (Kg/m2) | Median (range) | 28.79 [20.12, 42.45] | 31.66 [25.40, 42.45] | 26.60 [20.12, 37.79] | 0.071 |
| L1.2 vBMD (mg/cm3) | Median (range) | 118.95 [71.65, 186.45] | 126.03 [94.30, 170.40] | 118.95 [71.65, 186.45] | 0.545 |
| uNTX (nmol BCE/mmol·Cr) | Median (range) | 29.50 [11.00, 74.00] | 21.00 [11.00, 39.00] | 36.00 [15.00, 74.00] | 0.033 |
Distribution of FTIR parameters.
| Factor | Overall | Male | Female |
| |
|---|---|---|---|---|---|
|
| 22 | 9 | 13 | ||
| Min/Mat | Iliac trabecular | 4.27 [4.00, 5.32] | 4.24 [4.10, 5.32] | 4.36 [4.00, 4.72] | 0.664 |
| Iliac cortical | 4.50 [3.88, 6.26] | 4.48 [3.88, 6.26] | 4.60 [4.28, 5.42] | 0.305 | |
| Vertebral cortical | 4.52 [3.96, 5.30] | 4.93 [3.96, 5.30] | 4.34 [4.06, 4.84] | 0.112 | |
| Vertebral trabecular | 4.50 [3.84, 5.76] | 4.72 [3.86, 5.76] | 4.42 [3.84, 4.76] | 0.064 | |
|
| |||||
| C/P | Iliac trabecular | 0.0082 [0.0055, 0.0096] | 0.0081[0.0055, 0.0096] | 0.0082 [0.0073, 0.0092] | 0.893 |
| Iliac cortical | 0.00835 [0.0074, 0.0092] | 0.0081 [0.0077, 0.0092] | 0.0084 [0.0074, 0.0091] | 0.567 | |
| Vertebral trabecular | 0.0079 [0.0051, 0.0100] | 0.0080 [0.0051, 0.0089] | 0.00785 [0.0068, 0.0100] | 0.776 | |
| Vertebral cortical | 0.00855 [0.00530, 0.0105] | 0.0087 [0.0053, 0.0099] | 0.0083 [0.0074, 0.0105] | 0.647 | |
|
| |||||
| XLR | Iliac trabecular | 3.92 [3.16, 4.64] | 3.98 [3.28, 4.64] | 3.92 [3.16, 4.58] | 0.738 |
| Iliac cortical | 4.05 [3.14, 4.86] | 4.14 [3.40, 4.86] | 4.00 [3.14, 4.38] | 0.704 | |
| Vertebral trabecular | 4.34 [3.24, 5.40] | 4.26 [3.52, 5.40] | 4.36 [3.24, 5.12] | 0.859 | |
| Vertebral cortical | 4.28 [3.28, 5.00] | 4.44 [3.30, 5.00] | 4.24 [3.28, 4.62] | 0.676 | |
|
| |||||
| HPO4 | Iliac trabecular | 0.37 [0.34, 0.45] | 0.37 [0.34, 0.40] | 0.37 [0.34, 0.45] | 0.640 |
| Iliac cortical | 0.34 [0.28, 0.41] | 0.34 [0.28, 0.36] | 0.34 [0.30, 0.41] | 0.819 | |
| Vertebral trabecular | 0.38 [0.31, 0.47] | 0.38 [0.31, 0.41] | 0.38 [0.33, 0.47] | 0.702 | |
| Vertebral cortical | 0.35 [0.30, 0.40] | 0.36 [0.30, 0.40] | 0.34 [0.33, 0.38] | 0.941 | |
|
| |||||
| XST | Iliac trabecular | 1.22 [1.19, 1.24] | 1.21 [1.19, 1.24] | 1.22 [1.19, 1.24] | 0.616 |
| Iliac cortical | 1.22 [1.16, 1.25] | 1.22 [1.19, 1.25] | 1.24 [1.16, 1.25] | 0.470 | |
| Vertebral trabecular | 1.21 [1.14, 1.26] | 1.19 [1.14, 1.26] | 1.22 [1.16, 1.26] | 0.422 | |
| Vertebral cortical | 1.22 [1.16, 1.27] | 1.20 [1.16, 1.25] | 1.23 [1.20, 1.27] | 0.056 | |
Correlations between uNTX and FTIR parameters: univariate analyses.
| Male |
| Female |
|
| |||||
|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
| |||
| Age | −0.226 | 0.559 | −0.420 | 0.260 | 0.027 | 0.931 | 0.132 | 0.667 | |
| BMI | −0.219 | 0.571 | −0.277 | 0.470 | −0.116 | 0.706 | −0.399 | 0.177 | |
| L1.2 vBMD | 0.165 | 0.696 | 0.265 | 0.526 | 0.233 | 0.490 | 0.305 | 0.361 | |
|
| |||||||||
| Min/Mat | Iliac trabecular | −0.281 | 0.463 | −0.122 | 0.754 | 0.511 | 0.075 | 0.541 | 0.056 |
| Iliac cortical | −0.364 | 0.335 | −0.420 | 0.260 | 0.516 | 0.104 |
|
| |
| Vertebral trabecular | 0.480 | 0.191 | 0.588 | 0.096 | 0.158 | 0.624 | 0.221 | 0.491 | |
| Vertebral cortical | 0.243 | 0.530 | 0.412 | 0.271 | 0.183 | 0.589 | 0.210 | 0.536 | |
|
| |||||||||
| C/P | Iliac trabecular | 0.292 | 0.446 | 0.242 | 0.531 | 0.211 | 0.490 | 0.044 | 0.886 |
| Iliac cortical | 0.296 | 0.439 | 0.123 | 0.752 | 0.292 | 0.384 | 0.137 | 0.688 | |
| Vertebral trabecular | 0.578 | 0.103 | 0.655 | 0.055 | 0.306 | 0.334 | 0.474 | 0.120 | |
| Vertebral cortical | 0.330 | 0.386 | 0.266 | 0.489 | 0.008 | 0.981 | −0.069 | 0.841 | |
|
| |||||||||
| XLR | Iliac trabecular | −0.402 | 0.283 | −0.608 | 0.083 | 0.151 | 0.623 | 0.229 | 0.452 |
| Iliac cortical | − |
| − |
| 0.158 | 0.642 | 0.139 | 0.683 | |
| Vertebral trabecular | − |
| − |
| 0.088 | 0.786 | 0.214 | 0.505 | |
| Vertebral cortical | − |
| −0.605 | 0.084 | 0.123 | 0.719 | 0.155 | 0.649 | |
|
| |||||||||
| HPO4 | Iliac trabecular |
|
|
|
| −0.347 | 0.246 | −0.251 | 0.409 |
| Iliac cortical |
|
|
|
| −0.388 | 0.239 | −0.365 | 0.269 | |
| Vertebral trabecular | 0.516 | 0.155 | 0.454 | 0.220 | −0.024 | 0.940 | −0.102 | 0.753 | |
| Vertebral cortical |
|
|
|
| −0.021 | 0.951 | 0.105 | 0.759 | |
|
| |||||||||
| XST | Iliac trabecular | −0.551 | 0.124 | −0.546 | 0.128 | 0.334 | 0.264 | 0.331 | 0.270 |
| Iliac cortical | −0.124 | 0.750 | −0.042 | 0.915 | 0.352 | 0.288 | 0.337 | 0.311 | |
| Vertebral trabecular | −0.451 | 0.223 | −0.521 | 0.150 | −0.382 | 0.221 | −0.560 | 0.058 | |
| Vertebral cortical | −0.357 | 0.346 | −0.412 | 0.271 | 0.100 | 0.771 | −0.164 | 0.630 | |
Statistically significant variables shown in bold.
Figure 1The FTIR images of acid phosphate substitution in iliac crest trabecular bone. All numbers represent scales of micrometer. (a) Patients with high uNTX (39 nmol BCE/mmol·Cr). (b) Patients with low uNTX (14 nmol BCE/mmol·Cr).
The results of multivariate analyses with age adjustment.
| Male |
| Adjusted | Female |
| Adjusted | ||
|---|---|---|---|---|---|---|---|
|
|
|
|
| ||||
| Min/Mat | Iliac trabecular | −0.00825 | 0.580 | NA | 0.00716 | 0.063 | 0.319 |
| Iliac cortical | −0.01579 | 0.481 | 0.254 | 0.01024 | 0.070 | 0.352 | |
| Vertebral trabecular | 0.02964 | 0.169 | 0.077 | 0.00278 | 0.595 | NA | |
| Vertebral cortical | 0.01887 | 0.218 | 0.360 | 0.00300 | 0.524 | NA | |
|
| |||||||
| XLR | Iliac trabecular | −0.01686 | 0.316 | NA | 0.00269 | 0.630 | NA |
| Iliac cortical | −0.03270 | 0.069 | 0.273 | 0.00307 | 0.665 | NA | |
| Vertebral trabecular | −0.03896 | 0.061 | 0.389 | 0.00165 | 0.858 | NA | |
| Vertebral cortical | −0.03979 | 0.080 | 0.280 | 0.00250 | 0.738 | NA | |
|
| |||||||
| HPO4 | Iliac trabecular |
|
|
| −0.00058 | 0.268 | NA |
| Iliac cortical | 0.00173 | 0.073 | 0.401 | −0.00064 | 0.255 | NA | |
| Vertebral trabecular | 0.00139 | 0.220 | 0.043 | −0.00005 | 0.943 | NA | |
| Vertebral cortical |
|
|
| −0.00004 | 0.903 | NA | |
NA: not applicable (adjusted R2 values were below null value).